Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenAfriCar: Impact of MenAfriVac on Meningococcal Carriage
NCT01119482Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- May 2010
- Primary completion
- May 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 3
01
Overview
Phase 4, open-label, single-arm trial of MenAfriVac in meningococcal meningitis, sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Prevalence of meningococcal carriage at 6 months. Started May 2010; status: completed.
02
Drugs
MenAfriVac
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT01119482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119482.